Pine Tree Acquisition Corp.

Pine Tree Acquisition Corp. is a newly formed blank check company (SPAC) incorporated in the Cayman Islands, seeking to raise $100 million through an initial public offering of 10,000,000 units priced at $10.00 per unit. Each unit consists of one Class A ordinary share and one right to receive one-tenth of a Class A ordinary share upon consummation of an initial business combination. The company has no operating history, revenue, or identified target business, and its success is entirely dependent on management's ability to identify and complete a suitable business combination within 18 months.

The offering is structured with significant sponsor economics. Pine Tree Sponsor Group, LLC and North Penn, LLC, the co-sponsors, acquired 4,040,541 Class B founder shares for an aggregate of $25,000 (approximately $0.006 per share), representing approximately 35% ownership post-offering. The sponsors have also committed to purchase $1.4 million in private placement units simultaneously with the offering. This structure creates inherent conflicts of interest, as sponsors stand to profit substantially from a business combination even if public shareholders experience losses, while facing total loss if no transaction is consummated.

Financially, the company is in a pre-operational state with minimal resources. As of December 31, 2025, it held only $13,714 in cash, had a working capital deficit of $115,798, and an accumulated deficit of $18,206. The company's independent auditors have raised substantial doubt about its ability to continue as a going concern absent the successful completion of this offering. The proceeds from the IPO, along with the private placement, will fund the trust account with $100 million to be used for a future business combination.

The management team is led by Wei Qian, who serves as Chairman, CEO, and CFO, with a background in capital markets and private equity. The board includes three independent directors with expertise in financial risk management, business analytics, and biostatistics. However, the company operates under a dual-class share structure where Class B shareholders (sponsors) hold exclusive voting rights on director appointments and certain other matters prior to a business combination, effectively giving them control over the company's direction.

Key risks include the company's complete dependence on management's ability to source and complete a business combination, the limited 18-month timeframe to consummate a transaction, potential conflicts of interest between sponsors and public shareholders, and the lack of any current operations or revenue. The company targets businesses with enterprise values between $200 million and $2 billion and revenues between $50 million and $500 million, but faces competition from numerous other SPACs and private equity firms for attractive targets. The offering is underwritten by Maxim Group LLC, which will receive a 4.5% underwriting discount (0.5% cash, 4.0% in shares), and the securities are proposed to list on Nasdaq under the symbols PAXGU, PAXG, and PAXGR.